|
News releases may contain forward-looking statements, subject to risks and uncertainties beyond Nuvo's control. All news releases were accurate when issued. Actual results could differ materially from those expressed and Nuvo undertakes no obligation to revise the information in light of future events.
Year: 2010 : 2009 : 2008 :
2007
| November 25, 2008 |
Nuvo Research Subsidiary Signs Collaboration Agreement With Fortune Global 500 Company |
| October 30, 2008 |
Nuvo Announces Third Quarter 2008 Financial Results |
| October 27, 2008 |
Nuvo Research Presents Positive Phase III Study Results for Pennsaid at Leading Rheumatology Conference |
| September 18, 2008 |
Nuvo Announces Debenture Holders Agree to Resolution |
| August 1, 2008 |
Nuvo Announces Proposed Amendments to Outstanding Convertible Debentures |
| July 31, 2008 |
Nuvo Announces Second Quarter 2008 Financial Results |
| July 8, 2008 |
Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements |
| June 3, 2008 |
New Improved Dosing Approved for Pennsaid |
| May 29, 2008 |
Nuvo Licenses Topical Pain Product From Paladin |
| May 1, 2008 |
Nuvo Announces First Quarter 2008 Financial Results |
| February 21, 2008 |
Nuvo Announces 2007 Fourth Quarter and Year End Financial Results |
All news releases are in PDF format. To view the news releases you will need Adobe Acrobat Reader installed on your computer.
|
